News

TipRanks on MSN5d

AbbVie’s Phase 3 Study on Upadacitinib for Hidradenitis Suppurativa: A Potential Game Changer

Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 3 clinical study ...
TipRanks on MSN6d

AbbVie’s Promising Phase 3 Study on Upadacitinib for Vitiligo

Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 3 study titled A Phase ...